|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/32 | |
| A61K 9/51 | |||
| A61K 9/22 | |||
| A61K 9/16 | |||
| A61P 35/00 | |||
| A61K 9/19 | |||
| A61K 9/00 |
| (11) | Number of the document | 2379064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09835578.7 |
| Date of filing the European patent application | 2009-12-15 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/068028 |
| Date | 2009-12-15 |
| (87) | Number | WO 2010/075072 |
| Date | 2010-07-01 |
| (30) | Number | Date | Country code |
| 260200 P | 2009-11-11 | US | |
| 249022 P | 2009-10-06 | US | |
| 122479 P | 2008-12-15 | US |
| (72) |
ZALE, Stephen, E., US
TROIANO, Greg, US
ALI, Mir, Mukkaram, US
HRKACH, Jeff, US
WRIGHT, James, US
LOW, Susan, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (54) | LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |
| LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS |